A Randomized Trial of Incentives for Smoking Treatment in Medicaid Members

American Journal of Preventive Medicine
David L FraserTimothy B Baker

Abstract

Low-income populations are especially likely to smoke and have difficulty quitting. This study evaluated a monetary incentive intended to increase smoking treatment engagement and abstinence among Medicaid recipients who smoke. Two-group randomized clinical trial of Incentive (n=948) and Control interventions (n=952) for smoking. Medicaid recipients recruited from primary care patients (n=920) and callers to the Wisconsin Tobacco Quit Line (n=980). Participants were offered five quitline cessation calls and were encouraged to obtain cessation medication (covered by Medicaid). All participants received payment for completing a baseline assessment and a 6-month smoking test. Only Incentive condition participants received compensation for taking counseling calls ($30 per call) and for biochemically verified abstinence at the 6-month visit ($40). Seven-day point-prevalence smoking abstinence 6-months post study entry and cost/quit. Incentive condition participants had significantly higher biochemically determined 7-day point-prevalence smoking abstinence rates 6 months after study induction than did Controls (21.6% vs 13.8%, respectively, p<0.0001). A positive treatment effect of incentives was present across other abstinence indic...Continue Reading

Associated Clinical Trials

References

Sep 1, 1991·British Journal of Addiction·T F HeathertonK O Fagerström
Oct 4, 2002·The New England Journal of Medicine·Shu-Hong ZhuElsa Gutiérrez-Terrell
Mar 12, 2005·Annual Review of Public Health·K Michael Cummings, Andrew Hyland
Jun 17, 2005·Journal of Public Health Management and Practice : JPHMP·Jill M MurphyK Michael Cummings
Aug 9, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·David T LevyElizabeth Mumford
Jan 26, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kevin G VolppCaryn Lerman
Feb 1, 2006·Addiction·Jennifer Plebani LussierStephen T Higgins
Jun 17, 2006·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Kolawole S OkuyemiJasjit S Ahluwalia
Dec 6, 2007·American Journal of Preventive Medicine·Timothy A McAfee
Feb 14, 2009·The New England Journal of Medicine·Kevin G VolppJanet Audrain-McGovern
Jul 14, 2010·American Journal of Preventive Medicine·Travis P Baggett, Nancy A Rigotti
Oct 15, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jessica L ReidUNKNOWN ITC Collaboration
Oct 26, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Karl Fagerström
Jan 10, 2012·Preventive Medicine·Stephen T HigginsIra M Bernstein
Apr 25, 2012·Preventive Medicine·Stacey C Sigmon, Mollie E Patrick
Oct 6, 2012·Journal of Studies on Alcohol and Drugs·Bruce ChristiansenMichael C Fiore
Jul 19, 2013·The New England Journal of Medicine·Travis P BaggettNancy A Rigotti
Nov 1, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Beth C BockRaymond Niaura
Mar 13, 2014·Preventive Medicine·Dennis J HandStephen T Higgins
Jan 30, 2015·BMJ : British Medical Journal·David TappinUNKNOWN Cessation in Pregnancy Incentives Trial Team
May 15, 2015·The New England Journal of Medicine·Scott D HalpernKevin G Volpp
Oct 23, 2015·Addictive Behaviors·Jonathan S SlaterJon O Ebbert
May 22, 2016·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Jonathan S SlaterChristina L Nelson

❮ Previous
Next ❯

Citations

Apr 21, 2018·Current Opinion in Pulmonary Medicine·Hasmeena KathuriaEnid R Neptune
Mar 5, 2019·Health Affairs·Madhulika VulimiriCharlene A Wong
Jul 18, 2019·The Cochrane Database of Systematic Reviews·Caitlin NotleyJamie Hartmann-Boyce
Jan 30, 2020·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Floor A van den BrandConstant P van Schayck
Apr 3, 2020·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Elias M KlempererJessica W Cook
Jan 25, 2020·Perspectives on Behavior Science·Stephen T HigginsDanielle R Davis
Feb 28, 2021·Preventive Medicine·Ramzi G SalloumGraham W Warren
Nov 21, 2018·American Journal of Preventive Medicine·Christopher M AndersonShu-Hong Zhu
May 9, 2021·Annual Review of Clinical Psychology·Timothy B Baker, Danielle E McCarthy
Jun 8, 2021·Journal of Substance Abuse Treatment·Cara M MurphyPatricia Markham Risica

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.